We're extending our tissue-engineering technology into a new market: humanoid robotics. Our subsidiary, 3D Bio-Tissues (3DBT), has filed a priority patent application with the UK Intellectual Property Office covering a method for assembling tissue that can serve as a seamless outer covering for robotic hands and fingers. It's the same monolithic, stitchless 3D tissue architecture that 3DBT already uses in our luxury biomaterials work with Lab-Grown Leather, where it's under contracted, partner-funded evaluation with two tier-1 global luxury fashion houses. The opportunity here addresses a real engineering problem. As robotics companies move humanoid hands from prototypes to industrial deployment, the outer coverings on those hands keep failing: synthetic materials tear at the seams, restrict movement, and dull the sensors underneath. Our tissue platform is designed to be moulded as one continuous piece, tough where it needs grip and thin enough to flex at the joints, without blunting sensor feedback. Importantly, we intend to pursue this through Joint Development Agreements with robotics manufacturers, meaning partners would fund the tooling, integration and testing work rather than us. 3DBT would keep full ownership of its core IP, cell lines and media formulations throughout. This keeps our cash runway protected while opening a potential new revenue line as a component supplier if these agreements progress. It's worth being clear that this is an early-stage filing and a new commercial direction. No JDAs have yet been signed, and the images in the announcement are illustrative concepts, not existing products. If you have questions on this announcement, we'd encourage you to put them to us directly through our investor website.